Cell technologies in the treatment of rheumatic diseases
Rheumatic diseases are caused by chronic autoimmune processes that require long-term therapy, which leads to the formation of resistance to the drugs used. The search for new approaches to their treatment in recent years has been enriched with the use of cell therapy methods. They are considered in...
Main Authors: | N. F. Soroka, M. P. Potapnev, N. A. Martusevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2019-12-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2806 |
Similar Items
-
Pain in rheumatic diseases: how relevant is it?
by: P. Sarzi-Puttini, et al.
Published: (2014-06-01) -
Circulating level of regulatory T cells in rheumatic heart disease: An observational study
by: Saibal Mukhopadhyay, et al.
Published: (2016-05-01) -
Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment
by: Kevin Lynch, et al.
Published: (2017-10-01) -
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
by: Cantatore FP, et al.
Published: (2017-12-01) -
Osteoporosis and rheumatic diseases
by: N. Maruotti, et al.
Published: (2014-06-01)